In 1997 the FDA asked American Home Products (AHP), the makers of Pondimin (Fenfluramine) and Redux (Dexfenfluramine), to withdraw it's popular anti-obesity combination Fen-Phen drug from the market. AHP manufactured fenfluramine under the brand name Pondimin and AHP's subsidiary, Wyeth-Ayerst Laboratories, manufactured dexfenfluramine under the name Redux. Medical studies have linked Pondimin and Redux to heart valve disease...MORE >>
Featured Articles on Fen-Phen
- May 17, 2004 - Texas judge affirms $1 billion award in diet drug case
- April 20, 2004 - Majority Counsel Says Fen-Phen Trust Fund is Bust
- November 24, 2003 - 'Fen-Phen' Trust Seeks to Toss Claims
- May 21, 2003 - Thousands of Fen-Phen Patients Opt-Out of Class Action
- March 2, 2002 - American Home Products Settles Drug Suit
- September 17, 2001 - AHP still pursued by Fen-Phen specter
- September 10, 2001 - Lawsuits on the rise as Fen-Phen/Redux withdrawal approaches 4-year anniversary; cases against diet drug manufacturer could double
- July1, 2001 - Bitter Pill: The Fen-Phen story
- January 3, 2001 - Woman settles Fen-Phen case
- August 29, 2000 - Judge oks deal on drug linked to heart valve disease
Browse Books About Fen-Phen Drug Litigation
Injury and Product Liability...
in Product Liability and...